Introduction: Matthew Panuwat, a biotech executive, faces insider trading allegations from the Securities and Exchange Commission (SEC) despite not trading his employer’s stock or possessing inside information about his own company. His case, deemed as “shadow insider trading,” challenges existing laws and highlights the complexities surrounding insider trading definitions. 1. Legal Ambiguity and Regulatory Scrutiny:Continue reading “Insider Trading Case Tests Boundaries with “Shadow Insider Trading”
